Wegovy Shortages 2025

Wegovy Shortages 2025. Danish pharmaceutical giant novo nordisk will boost supplies of its wildly popular obesity drug wegovy in the united states this year, mitigating—but likely not. While wegovy and ozempic contain the same active ingredient, the approved.

A shortage happens when there’s not enough of the drug to meet the demand,. The company is limiting how much of the starting dose of wegovy it produces to focus on supplying the drug to patients already on it and who work their way up to higher.